Tag: Big Pharma

Commentary: Big Pharma’s Wokeness

South Carolina Sun Staff
Pfizer COVID vaccine

Big Pharma is not your friend. Whether it’s hiking up drug prices or bribing the Swamp, the pharmaceutical industry works against the people’s interests. Many Americans are aware of Big Pharma’s greed and the power it wields over Washington, D.C., but fewer are aware of just how left-wing the industry is. It serves as a cash cow for the left and pushes woke ideas on its employees and the country at large. This may explain why Democrats, who act like they hate Big Pharma, serve the industry’s interests.

While the drugmakers spread their cash around all of DC, they overwhelmingly prefer Democrats. In recent elections, Big Pharma donated significantly more money to Democratic candidates than Republican candidates. From 2016 to 2022, the industry gave a whopping $29 million to Democratic candidates. This trend stands true for the current election cycle, with more cash going to Democrats once again. This favoritism extends to the presidential race. The drug lobby has donated four times more money to Joe Biden than it has to Donald Trump. And the industry’s generosity to Team Blue doesn’t end with individual candidates. Its chief lobby, PhRMA, also gives millions to liberal campaign arms like the Democratic Attorneys General Association.

Read More

Big Pharma Raises Hundreds of Drug Prices Despite Biden Admin Efforts to Keep Costs Down

South Carolina Sun Staff
Pharmacist

Top pharmaceutical companies raised the list price on 775 brand-name drugs in just the first half of January, even as President Joe Biden aims to keep prices low, according to The Wall Street Journal.

The median price hike of the drugs was around 4.5%, with some rising by 10% or more, despite an inflation rate of 3.4% year-over-year in December, according to data from 46brooklyn Research acquired by the WSJ. The price hikes are in contrast to the president’s efforts to tame rising drug prices, taking actions such as imposing automatic rebates to Medicare for drugmakers that raise their prices faster than the price of inflation, which first went into effect in December, affecting 48 drugs covered under Medicare Part B.

Read More